Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Star Lake Bioscience is a China-based listed biotechnology and biochemical manufacturing company focused on bio-fermentation and chemical synthesis. The company produces biochemical active pharmaceutical ingredients, pharmaceutical intermediates, nutraceutical and nutrition ingredients, feed additives, and food additives, and also markets selected finished pharmaceutical products. Its healthcare-related portfolio includes products such as ribavirin, inosine, adenosine, adenine, memantine hydrochloride, L-proline, and adefovir dipivoxil tablets, alongside broader nucleotide and amino-acid product lines. Star Lake also serves as the listed biotechnology and food business platform of Guangdong Guangxin Holdings Group and operates multiple production bases with international commercial reach. Overall, it is better characterized as a commercial-scale biochemical manufacturer than as a drug-discovery biotech with a traditional innovative clinical pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Star Lake.